Anticoagulation in cardiovascular diseases: Evolving role, unmet needs and grey areas

Anticoagulation in cardiovascular diseases: Evolving role, unmet needs and grey areas PDF Author:
Publisher: Frontiers Media SA
ISBN: 2832520731
Category : Medical
Languages : en
Pages : 236

Get Book Here

Book Description

Anticoagulation in cardiovascular diseases: Evolving role, unmet needs and grey areas

Anticoagulation in cardiovascular diseases: Evolving role, unmet needs and grey areas PDF Author:
Publisher: Frontiers Media SA
ISBN: 2832520731
Category : Medical
Languages : en
Pages : 236

Get Book Here

Book Description


Cardiovascular Biomarkers

Cardiovascular Biomarkers PDF Author: David A. Morrow
Publisher: Springer Science & Business Media
ISBN: 1597450510
Category : Medical
Languages : en
Pages : 612

Get Book Here

Book Description
In the four pages committed to a discussion of myocardial infarction in the first edition of Harrison’s Principles of Internal Medicine, published in 1950, there was no mention of use of the laboratory for management of patients. Thirty years later, when the first edition of Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine was published, 2 out of the 1943 pages in the text contained a discussion of the laboratory examinations in acute myocardial infarction. Our knowledge base of the multitude of ways that physicians can and should use the clinical chemistry laboratory has expanded dramatically since these classic texts were published. The nomenclature has changed: terms such as “cardiac enzymes” have given way to “cardiac biomarkers. ” The number of assays has multiplied, and the operating characteristics of available assays are impr- ing at a gratifying but dizzying rate. We now use biomarkers to diagnose cardiovascular diseases and also to frame our treatment strategies. Thus, there is a clear need for a scholarly compilation of the state of the art of cardiac biomarkers. Dr. David Morrow has expertly edited an authoritative book that answers this need. The 34 chapters in Cardiovascular Biomarkers: Pathophysiology and Disease Mana- ment were written by a group of individuals who are internationally recognized thought leaders and experts in clinical and laboratory medicine.

Acute Rheumatic Fever and Rheumatic Heart Disease

Acute Rheumatic Fever and Rheumatic Heart Disease PDF Author: Dr. Scott Dougherty
Publisher: Elsevier Health Sciences
ISBN: 0323754600
Category : Medical
Languages : en
Pages : 364

Get Book Here

Book Description
Acute Rheumatic Fever and Rheumatic Heart Disease is a concise, yet comprehensive, clinical resource highlighting must-know information on rheumatic heart disease and acute rheumatic fever from a global perspective. Covering the major issues dominating the field, this practical resource presents sufficient detail for a deep and thorough understanding of the latest treatment options, potential complications, and disease management strategies to improve patient outcomes. - Divided into four distinct sections for ease of navigation: Acute Rheumatic Fever, Rheumatic Heart Disease, Population-Based Strategies for Disease Control, and Acute and Emergency Presentations. - International editors and chapter authors ensure a truly global perspective. - Covers all clinical aspects, including epidemiology, pathophysiology, clinical features, diagnosis, management, and treatment. - Includes key topics on population-based measures for disease control for effective primary, secondary, and tertiary prevention. - Consolidates today's available information and guidance into a single, convenient resource.

Emerging Technologies for Heart Diseases

Emerging Technologies for Heart Diseases PDF Author: Udi Nussinovitch
Publisher: Academic Press
ISBN: 0128137053
Category : Medical
Languages : en
Pages : 594

Get Book Here

Book Description
The increasing pace of advances in cardiology throughout the last few decades has fundamentally altered the natural course of heart patients. In the last few years, available therapies have been revolutionized completely by new transcatheter therapeutic approaches, novel ventricular assist devices, and new drugs. Also, molecular biology and genetics have a rapidly growing impact on cardiovascular diseases, enabling the field of regenerative medicine to become increasingly closer to routine clinical implementation. Emerging Technologies for Heart Diseases was conceived to cover the recent extensive literature on current and novel therapeutic options for cardiac patients. The first volume is dedicated to heart failure and valvular disorders, and the second covers myocardial ischemia and arrhythmias. The clinical topic is addressed in several chapters divided according to the therapeutic approach (mechanical or electrical device-based, or cell and gene-based). Each of the 46 chapters focuses on clinically available solutions, new therapies currently under evaluation in clinical trials, promising preclinical technologies, and emerging concepts and innovations that have not yet been tested in a preclinical model. Also, the book discusses future challenges and opportunities for clinical implementation. Lessons learned from abandoned experimental practices are also covered, giving the readers the widest possible perspective of current therapeutic dilemmas. Overall, this textbook was designed for physicians who want to stay up-to-date with current therapies and those of the future, for biomedical companies, and for those who wish to broaden their knowledge of new cardiovascular therapeutic options. - Provides a comprehensive review of the latest therapeutic developments for heart failure, valvular disorders, myocardial ischemia and arrhythmias, and their clinical implications - Written by both specialists in the field and established researchers, it delivers a review of emerging medical technologies and presents insight into their therapeutic promise - Chapters are arranged according to disease pathogeneses and relevance and include coverage of the mechanical, electrophysiological, and biological approaches for the management of patients with myocardial ischemia and arrhythmias

Oral Anticoagulants

Oral Anticoagulants PDF Author: L. Poller
Publisher: CRC Press
ISBN: 9780340552667
Category : Medical
Languages : en
Pages : 288

Get Book Here

Book Description
Warfarin and related drugs have been used for over half a century in prevention and treatment of thrombotic disorders. Only recently however has their clinical role been firmly established by randomised studies and their benefit/risk ratio improved by lower dose therapy with improvements in laboratory monitoring. 'Oral Anticoagulants' is the first comprehensive, practical survey of the subject available. An international team of recognised experts provide detailed coverage on the mode of action; clinical pharmodynamics; magnitude and sources of variability in individuals response to oral anticoagulant; methods of individualising dosing regimens; laboratory monitoring; and comparison between the different currently prescribed oral anticoagulants.

Introduction to Health Care Delivery

Introduction to Health Care Delivery PDF Author: Robert L. McCarthy
Publisher: Jones & Bartlett Publishers
ISBN: 0763790885
Category : Business & Economics
Languages : en
Pages : 644

Get Book Here

Book Description
Introduction to Health Care Delivery:A Primer for Pharmacists, Fifth Edition provides students with a current and comprehensive overview of the U.S. health care delivery system from the perspective of the pharmacy profession. Each thoroughly updated chapter of this best-selling text includes real-world case studies, learning objectives, chapter review questions, questions for further discussion, and updated key topics and terms. New and expanded topics include public health, pharmacoepidemiology, cultural competence, and leadership. Patient-Provider dialogues are also included to help students apply key concepts. Instructor Resources include a Transition Guide, PowerPoint Presentations, and an Instructor's Manual.Key Features* Case Scenario per Chapter* Learning Objectives* Chapter Review Questions* Doctor/Patient Scripts* Questions for Further Discussion* ReferencesEach new textbook includes an online code to access the Student Resources available on the Companion Website. Online access may also be purchased separately.*Please note: Electronic/eBook formats do not include access to the Companion Website.

Direct Oral Anticoagulants

Direct Oral Anticoagulants PDF Author: Riccardo Proietti
Publisher: Springer Nature
ISBN: 3030744620
Category : Medical
Languages : en
Pages : 283

Get Book Here

Book Description
This book concisely covers the latest developments in the application of direct oral anticoagulants (DOACs) within cardiovascular medicine. It details the pharmacodynamics and pharmacokinetic mechanisms of DOACs and their application in treating patients with conditions ranging from coronary heart disease through kidney disease and cancer, including their perioperative management. Direct Oral Anticoagulants: From Pharmacology to Clinical Practice systematically describes the underlying mechanisms associated with DOACs and their use to treat a range of conditions and is an indispensable resource for all trainee and practicing physicians in a range of disciplines seeking a concise up-to-date resource on the topic.

Secondhand Smoke Exposure and Cardiovascular Effects

Secondhand Smoke Exposure and Cardiovascular Effects PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309138396
Category : Medical
Languages : en
Pages : 240

Get Book Here

Book Description
Data suggest that exposure to secondhand smoke can result in heart disease in nonsmoking adults. Recently, progress has been made in reducing involuntary exposure to secondhand smoke through legislation banning smoking in workplaces, restaurants, and other public places. The effect of legislation to ban smoking and its effects on the cardiovascular health of nonsmoking adults, however, remains a question. Secondhand Smoke Exposure and Cardiovascular Effects reviews available scientific literature to assess the relationship between secondhand smoke exposure and acute coronary events. The authors, experts in secondhand smoke exposure and toxicology, clinical cardiology, epidemiology, and statistics, find that there is about a 25 to 30 percent increase in the risk of coronary heart disease from exposure to secondhand smoke. Their findings agree with the 2006 Surgeon General's Report conclusion that there are increased risks of coronary heart disease morbidity and mortality among men and women exposed to secondhand smoke. However, the authors note that the evidence for determining the magnitude of the relationship between chronic secondhand smoke exposure and coronary heart disease is not very strong. Public health professionals will rely upon Secondhand Smoke Exposure and Cardiovascular Effects for its survey of critical epidemiological studies on the effects of smoking bans and evidence of links between secondhand smoke exposure and cardiovascular events, as well as its findings and recommendations.

The Changing Role of the Hospital in European Health Systems

The Changing Role of the Hospital in European Health Systems PDF Author: Martin McKee
Publisher: Cambridge University Press
ISBN: 1108790054
Category : Health & Fitness
Languages : en
Pages : 327

Get Book Here

Book Description
A team of world-leading policy experts and clinicians analyse the changing role of the hospital across Europe.

Atrial Fibrillation Therapy

Atrial Fibrillation Therapy PDF Author: Gheorghe-Andrei Dan
Publisher: Springer Science & Business Media
ISBN: 1447154754
Category : Medical
Languages : en
Pages : 200

Get Book Here

Book Description
The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication. New guidelines have emerged as a result of new mechanisms for initiation and perpetuation for pharmacotherapy to cure AF and trials with new classes of antithrombotic drugs are ongoing. The treatment of AF is still in its infancy, but recent research is revealing how it can be applied with optimal efficacy. This book assists trainees, recertifying physicians, practicing physicians and other professional staff in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply new diagnostic tools for selecting the best treatment options for AF patients.